HIQA publishes updated national guidelines for conducting economic evaluation and budget impact analysis in HTAs

Today the Health Information and Quality Authority (HIQA) has published updated guidelines for conducting economic evaluation and budget impact analysis in health technology assessments (HTAs). The guidelines are intended to inform economic evaluations or budget impact analyses conducted by, or on behalf of HIQA, the National Centre for Pharmacoeconomics (NCPE), the Department of Health and the Health Service Executive, as well as health technology developers preparing applications for reimbursement.

HTAs are used to help decide which health technologies (such as drugs, procedures, medical devices, broader public health interventions and service delivery models) should form part of the publicly-funded health and social care system. It is therefore important that best-practice methodologies are used when conducting HTAs. A suite of national HTA guidelines has been developed by HIQA based on international best practice. HIQA updates these guidelines to ensure they incorporate the most up-to-date and relevant scientific information, based on research and experience both nationally and internationally.